40000
Annual output of the 40,000-ton taurine project
3000
Annual output of 30 million liters of health functional beverages
300+
Over 300 professional technical personnel
2026
The Yuanqi Xiaoshu brand has launched nationwide investment promotion and rolled out more than 10 sports nutrition and light health products tailored to the health needs of young and middle-aged groups, including taurine caffeine drinks.
2025
The Shengyuan Shu brand has launched national investment promotion, with 40 brand exhibition halls opened as of May 2026.
2023
A bioscience research institute has been set up to focus on research into production processes and technologies for taurine raw materials, boasting the second-largest production base nationwide.
2022
Established Shengyuan Pharmaceutical and Kangjian Pharmaceutical, focusing on the R&D and production of food and pharmaceutical products, and striving to become the world's top taurine brand.
2020
Listed on the ChiNext Board of Shenzhen Stock Exchange, the Company actively expands its businesses in new energy, pharmaceuticals, food and big health industries.
2006
We have laid out the domestic waste incineration power generation sector and currently own 13 relevant projects.
2004
We entered the environmental protection sector and invested in domestic sewage treatment projects, currently operating five sewage treatment plants including Baozhou Sewage Treatment Plant.
Vision
To become the world’s No.1 taurine brand and build a benchmark enterprise in China’s functional beverage industry.
Mission
Relying on the advantages of the whole industrial chain, centered on scientific formulas and based on safe quality standards, we deliver healthy, high-efficiency and low-burden products.
Position
Shengyuan Environmental is the core operating entity for its big health industry, focusing on the R&D, production and sales of a full range of taurine health products.
The company’s 40,000-ton/year taurine production project for pharmaceutical and food raw materials has been designated as a Key Project of Fujian Province in 2024. The project involves a total investment of approximately 749 million yuan, covers a land area of 75.05 mu, and boasts a total construction area of 38,844 square meters. Built in strict accordance with international quality management systems including ISO9001, ISO22000 and FSSC22000, as well as pharmaceutical GMP standards, the project will turn the enterprise into the world’s second-largest taurine producer once fully completed.
The first phase project of the company's food and pharmaceutical health industry plans to build a new production line with an annual output of 30000 kiloliters of beverages (taurine beverages and collagen beverages), 30000 tons/year of puffed dry food, and 1200 tons/year of freeze-dried cat food and health products (effervescent tablets, tablets, capsules, compressed candies, etc.), with a total investment of approximately 397 million yuan.
